You are here

Novo Nordisk board looking for new CEO

Tel Aviv

NOVO Nordisk's board is working to find a replacement for chief executive officer Lars Rebien Soerensen, who led the Danish company to one of the best stock market performances of any drugmaker over the past 14 years.

Mr Rebien Soerensen, 60, is unlikely to remain in the...

Market voices on: